CALCULATE YOUR SIP RETURNS

Tata Chemicals Arm To Invest Rs 655 Crore in a Sodium Bicarbonate Plant in the UK

13 November 20243 mins read by Angel One
Tata Chemicals Europe is investing Rs.655 crore in a UK sodium bicarbonate plant, tripling output by 2027; shares trade at Rs.1,060.80, up 12.06% yearly.
Tata Chemicals Arm To Invest Rs 655 Crore in a Sodium Bicarbonate Plant in the UK
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Tata Chemicals Europe Ltd (TCEL), a wholly-owned subsidiary of Tata Chemicals, has announced a major capital investment of £60 million (approximately Rs.655 crore) to establish a state-of-the-art pharmaceutical grade sodium bicarbonate plant in Northwich, UK.  This facility will be a game-changer, tripling TCEL’s current output of sodium bicarbonate used in medicines and hemodialysis. 

Construction begins in 2025, and by 2027, the plant will be fully operational, running on an eco-friendly process that captures carbon dioxide from energy emissions. Yes, turning pollution into a raw material, is pretty innovative, right?

Closing Doors to Open New Ones

To fund this expansion, TCEL is making tough choices. Their loss-making Lostock plant, which contributed Rs.1,200 crore to Tata Chemicals’ turnover last year (about 8%), will shut down by January 2025. This decision wasn’t made lightly and will involve consultations with employees, as required under UK laws. It’s clear TCEL is ready to shift focus from outdated operations to future-forward projects with higher potential.

Finding the Funds

The investment of Rs.655 crore will be financed through a combination of internal accruals and debt, providing a balanced funding approach. This comes at a time when Tata Chemicals is facing a challenging financial environment. In Q2FY25, the company reported a net profit of Rs.267 crore, a 46% decline from Rs.495 crore in the same period last year. Revenue remained flat at Rs.3,999 crore, while EBITDA dropped by 25% to Rs.618 crore. 

Tata Chemicals shares are trading at Rs.1,060.80 currently, down 1.08% today, 5.08% year-to-date, but up 12.06% over the past year.

Conclusion: This isn’t just about building a plant, it’s about building the future. By investing in high-demand pharmaceutical-grade products and aligning with sustainability goals, Tata Chemicals is setting itself apart in the global market. While the road to 2027 is coming with challenges, the payoff could redefine its position in the industry. This is more than a business move, it’s a transformation.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Enjoy ₹0 Account Opening Charges

Join our 2 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Send App Link
Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Enjoy ₹0 Account Opening Charges